Crowdonomics
WatchlistPortfolio
CALIBRE BIOMETRICS

Reg CF · Common Stock · Jan 2023

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$58.9K / $1.2M max
5% of ceiling · target hit day 14
Investors
32
$2.2K avg
Post-money valuation
$22.8M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$70K$35K$0
32160
Jan 17, 2023 · openedMar 21, 2023 · last reading
Target ($15K) hit — Jan 31, 2023, day 14Deadline Mar 20, 2023

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$0
−$475K
FY2020
$0
−$1.8M
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$475,411
-$1,753,269
Taxes paid
$0
$0
Balance sheet
Cash
$19,054
$431,447
Accounts receivable
$0
$0
Total assets
$19,054
$439,915
Short-term debt
$91
$329,808
Long-term debt
$0
$450,000
Total liabilities
$91
$779,808
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$22.8M
Post-money$22.8M
Price / share$2.50
Shares offered6,000

Perks

Invest within the first three weeks and receive 10% bonus shares10% bonus

Offering details

Target$15,000
Max$1,235,000
Min investment$500
OpenedJan 17, 2023
DeadlineMar 20, 2023
ClosedMar 20, 2023
Days active62

Links & provenance

Campaign pagePitch videoSEC filing
Source: Manual
0001665160-23-000106
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.